TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.
about
Human but not mouse adipogenesis is critically dependent on LMO3Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolismCaspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease.P65 inactivation in adipocytes and macrophages attenuates adipose inflammatory response in lean but not in obese mice.Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.A major role of insulin in promoting obesity-associated adipose tissue inflammation.An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors.TWEAK: A New Player in Obesity and Diabetes.TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes.Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women.The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.Lentivirus-mediated angiopoietin-2 gene silencing decreases TNF-α induced apoptosis of alveolar epithelium cells.TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.Caspases in metabolic disease and their therapeutic potential.Developing TRAIL/TRAIL death receptor-based cancer therapies.
P2860
Q24297394-C97B6888-0817-440F-A452-1E9DA5C39B36Q28085224-E3E578A6-BB5A-4C1D-9253-554C4CE1887DQ33586821-92A5C31B-DFB2-4758-A9C3-16CCE0D31529Q35178548-B984025F-B9BC-4BAC-A005-8520C8348E29Q35438444-64EAC0F3-271F-4E31-A5C2-5D4FC8483FB9Q35774778-63C1802E-5AF6-4640-B102-182B8C49FB5AQ35783848-FE5D9930-07D3-4E3C-AB96-AAEF39278580Q37399332-CE25D7FF-CB84-458E-B839-130CA7B8673DQ37465838-5C754656-B60F-4941-9B37-8D77D834C320Q38177788-84EF1DA2-ED22-41C1-B67C-A8DC7BA9C4CAQ39817074-EE258D5A-C7ED-446D-90AA-8F4337296053Q41051062-503F3B36-1BB1-40F8-A299-F5AA32928D62Q43379345-F3E9A00A-0213-464E-B063-FD46FE08A519Q47832405-A6B56E96-EA76-4D9D-B50C-230D91A25805Q51433001-D4D695CB-D139-4D58-B04C-24F335D92C2AQ52745207-2725C46A-48ED-463C-8518-A96D6FA99195Q53685192-8BA75A72-36F7-4A1D-925D-8F91AC8DD2BAQ53701901-7091C097-1E42-49E8-A70D-702D44F7C003
P2860
TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@ast
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@en
type
label
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@ast
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@en
prefLabel
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@ast
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@en
P2093
P2860
P356
P1476
TRAIL (TNF-related apoptosis-i ...... ediated cleavage of PPARgamma.
@en
P2093
I Wernstedt Asterholm
K-M Debatin
M-A Westhoff
P E Scherer
P2860
P2888
P356
10.1038/CDDIS.2012.212
P577
2013-01-24T00:00:00Z
P5875
P6179
1006674204